scholarly article | Q13442814 |
P356 | DOI | 10.1191/0961203303LU259OA |
P698 | PubMed publication ID | 12587823 |
P2093 | author name string | N E Bianco | |
F Tápanes | |||
I Daboin | |||
J Atahualpa Pinto | |||
M Zabaleta-Lanz | |||
R E Vargas-Arenas | |||
P2860 | cites work | Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications | Q24561689 |
The 1982 revised criteria for the classification of systemic lupus erythematosus | Q29547225 | ||
Etiopathogenesis of systemic lupus erythematosus | Q34051411 | ||
Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histologic data | Q36748174 | ||
Lupus: Key Pathogenic Mechanisms and Contributing Factors | Q40430858 | ||
Outcome of silent lupus nephritis | Q41165180 | ||
Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study | Q41192552 | ||
Progression of mesangial and focal to diffuse lupus nephritis | Q43460182 | ||
Treatment of lupus nephritis--a work in progress | Q44237278 | ||
Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. | Q44441787 | ||
Precise Standardization of Reagents for Complement Fixation | Q53789356 | ||
P433 | issue | 1 | |
P921 | main subject | systemic lupus erythematosus | Q1485 |
P304 | page(s) | 26-30 | |
P577 | publication date | 2003-01-01 | |
P1433 | published in | Lupus | Q6704846 |
P1476 | title | Silent nephritis in systemic lupus erythematosus | |
P478 | volume | 12 |
Q89099443 | A Systematic Review and Meta-analysis of Prevalence of Biopsy-Proven Lupus Nephritis |
Q35223839 | A retrospective analysis of clinical presentation of lupus nephritis |
Q37486571 | Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes. |
Q51048045 | Assessment of a lupus nephritis cohort over a 30-year period. |
Q44619108 | Association of hydrophobically-modified poly(ethylene glycol) with fusogenic liposomes |
Q41540102 | Consensus of the Brazilian Society of Rheumatology for the diagnosis, management and treatment of lupus nephritis |
Q91711792 | Deep Phenotyping of Urinary Leukocytes by Mass Cytometry Reveals a Leukocyte Signature for Early and Non-Invasive Prediction of Response to Treatment in Active Lupus Nephritis |
Q33728412 | Deficiency of activating Fcγ-receptors reduces hepatic clearance and deposition of IC and increases CIC levels in mercury-induced autoimmunity |
Q46484861 | Efficacy of enteric-coated mycophenolate sodium in patients with resistant-type lupus nephritis: a prospective study. |
Q37833831 | Hypercalcaemia in systemic lupus erythematosus. |
Q51792764 | Investigation of pathological and clinical features of lupus nephritis in 73 autopsied cases with systemic lupus erythematosus. |
Q37834473 | Lupus nephritis in Colombians: contrasts and comparisons with other populations |
Q64884426 | Lupus nephritis: low urinary DNase I levels reflect loss of renal DNase I and may be utilized as a biomarker of disease progression. |
Q37800295 | Major lupus organ involvement: severe lupus nephritis |
Q38777083 | Modular transcriptional repertoire analyses identify a blood neutrophil signature as a candidate biomarker for lupus nephritis. |
Q36600357 | Outcome and predictors of kidney disease progression in Puerto Ricans with systemic lupus erythematosus initially presenting with mild renal involvement. |
Q46100560 | Renin-angiotensin system gene polymorphisms predict the progression to renal insufficiency among Asians with lupus nephritis |
Q33340963 | Role of anti-C1q autoantibodies in the pathogenesis of lupus nephritis |
Q53620564 | Spot urine protein/creatinine ratio is unreliable estimate of 24 h proteinuria in lupus nephritis when the histological scores of activity index are higher. |
Q35562033 | The clinical art and science of urine microscopy |
Q60302954 | The potential diagnostic utility of coexpression of Ki-67 and P53 in the renal biopsy in pediatric lupus nephritis |
Q47619092 | Treatable renal disease in children with silent lupus nephritis detected by baseline biopsy: association with serum C3 levels |
Q37638666 | Urinary Albumin Levels are Independently Associated with Renal Lesion Severity in Patients with Lupus Nephritis and Little or No Proteinuria |
Q64992316 | Urine TWEAK level as a biomarker for early response to treatment in active lupus nephritis: a prospective multicentre study. |
Q36633311 | Urine VCAM-1 as a marker of renal pathology activity index in lupus nephritis |
Search more.